TCL Archive NCI Bypass Budget An Underutilized Document and Ignored By MB; Deserves Attention Of Congress January 20, 1989
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive An “insurgency” targets randomized trials, demands access to investigational drugs. August 5, 2005
TCL Archive Switching to Tasigna After Gleevec Therapy Can Achieve Deeper Molecular Response December 28, 2012
